Neonatal Chimerization with Human Glial Progenitor Cells Can Both Remyelinate and Rescue the Otherwise Lethally Hypomyelinated Shiverer Mouse  by Windrem, Martha S. et al.
Cell Stem Cell
ArticleNeonatal Chimerization with Human Glial Progenitor
Cells Can Both Remyelinate and Rescue the
Otherwise Lethally Hypomyelinated Shiverer Mouse
Martha S. Windrem,1 Steven J. Schanz,1 Min Guo,1 Guo-Feng Tian,2 Vaughn Washco,1 Nancy Stanwood,3
Matthew Rasband,4 Neeta S. Roy,5 Maiken Nedergaard,2 Leif A. Havton,6 Su Wang,1 and Steven A. Goldman1,2,*
1Department of Neurology
2Department of Neurosurgery
3Department of Obstetrics and Gynecology
University of Rochester Medical Center, Rochester, NY 14642, USA
4Department of Neurobiology, Baylor University College of Medicine, Houston, TX 77030, USA
5Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY 10065, USA
6Department of Neurology, UCLA Medical Center, Los Angeles, CA 90095, USA
*Correspondence: steven_goldman@urmc.rochester.edu
DOI 10.1016/j.stem.2008.03.020SUMMARY
Congenitally hypomyelinated shiverer mice fail to
generate compact myelin and die by 18–21 weeks
of age. Using multifocal anterior and posterior fossa
delivery of sorted fetal human glial progenitor cells
into neonatal shiverer 3 rag2/ mice, we achieved
whole neuraxis myelination of the engrafted hosts,
which in a significant fraction of cases rescued this
otherwise lethal phenotype. The transplanted mice
exhibited greatly prolonged survival with progressive
resolution of their neurological deficits. Substantial
myelination in multiple regions was accompanied
by the acquisition of normal nodes of Ranvier and
transcallosal conduction velocities, ultrastructurally
normal and complete myelination of most axons,
and a restoration of a substantially normal neurolog-
ical phenotype. Notably, the resultant mice were
cerebral chimeras, with murine gray matter but a
predominantly human white matter glial composi-
tion. These data demonstrate that the neonatal trans-
plantation of human glial progenitor cells can effec-
tively treat disorders of congenital and perinatal
hypomyelination.
INTRODUCTION
Glial progenitor cells and the neural stem cells from which they
derive may be isolated and transplanted into myelin-deficient
hosts, as a means of introducing new oligodendrocytes able to
myelinate host axons (Archer et al., 1997; Eftekharpour et al.,
2007; Learish et al., 1999; Mitome et al., 2001; Yandava et al.,
1999). We have previously noted that enriched preparations of
human glial progenitor cells, when engrafted into the neonatal
shiverer mouse—a mutant that lacks full-length myelin basic
protein (Popko et al., 1987; Readhead et al., 1987; Roach
et al., 1985)—generate substantial myelin in these otherwiseunmyelinated recipients (Windrem et al., 2004) However, the
potential utility of this approach to the development of clinical
remyelination strategies has been unclear, as previous studies
have failed to note significant brainstem, cerebellar, or spinal en-
graftment from intracerebral grafts, and no effect on disease
phenotype or survival has yet been reported in hypomyelinated
mice as a consequence of progenitor cell transplantation
(reviewed in Goldman, 2005; Keyoung and Goldman, 2007).
Our initial study of the efficacy of isolated human glial progenitors
revealed no overt effect of cell transplantation on either the con-
dition or fate of the engrafted recipients; despite widespread
forebrain myelination, the transplanted mice typically died be-
tween 18 and 21 weeks of age, just as did unengrafted shiverers.
In the present study, using a newly developed set of ap-
proaches to cell acquisition and transplantation, we attempted
a far more extensive and higher-density cell engraftment than
any previously noted. Our aim in doing so was to achieve suffi-
ciently widespread central myelination so as to influence the
phenotype and survival of the recipient animals. To avoid rejec-
tion as a complicating variable in these experiments, we crossed
shiverers with rag2 null immunodeficient mice (Shinkai et al.,
1992), and thereby generated an immunodeficient line of
congenitally hypomyelinated mice in which to assess graft
efficacy and effect. Using these double-homozygous rag2/ 3
shiverershi/shi mice, we established a multisite injection protocol,
with concurrent bilateral hemispheric and cerebellar cell injec-
tions delivered at birth. This procedure resulted in widespread
donor cell engraftment throughout the neuraxis, with infiltration
of the forebrain, brainstem, and cerebellum, and ultimately the
spinal cord and roots. The engrafted human glial progenitor cells
exhibited robust, efficient, and functional myelination, with pro-
gressive ensheathment of host axons and restoration of normal
nodes of Ranvier and attendant conduction velocities. This ulti-
mately led to the high-efficiencymyelination of themajor intrace-
rebral, ascending, and descending tracts, the cranial nerves and
intracranial ganglia, and the spinal cord to the thoracolumbar
level.Most notably, the implanted animals exhibited a substantial
recovery of normal neurological phenotype, such that a fraction
were frankly rescued by perinatal transplantation, surviving wellCell Stem Cell 2, 553–565, June 2008 ª2008 Elsevier Inc. 553
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Cell Therapy Rescue of a Congenital Leukodystrophyover a year until sacrificed for histology, which revealed a remye-
linated—and essentially humanized—central white matter. The
neurological recovery and sustained survival of these trans-
planted mice was in sharp contrast to the fate of their untreated
controls, which uniformly died by 5 months of age. To our knowl-
edge, these data represent the first outright rescue of a congen-
ital hypomyelinating disorder by means of a stem or progenitor
cell transplantation and indicate that neonatal glial progenitor
cell transplantation may prove an effective means of treating
disorders of hereditary and perinatal hypomyelination.
RESULTS
Engrafted Shiverer Mice Exhibited Substantially
Prolonged Survival
Newborn double-homozygous shiverer (shi/shi) 3 rag2/ im-
munodeficient mice were implanted with either 300,000 human
glial progenitor cells (GPCs; n = 26), with PBS vehicle control
(n = 29), or with nothing (n = 59). Cells were delivered at five sites,
including the anterior and posterior corpus callosa bilaterally,
and the presumptive cerebellar peduncle as a single midline in-
jection; PBS controls received equal volume injections at each
site, while the no-injection controls were not injected. The mice
were then returned to their mothers and allowed to develop nor-
mally, with weaning at 21 days and small-group housing thereaf-
ter. All mice were observed to undergo progressive neurological
deterioration, typically first manifest by progressive truncal insta-
bility, worse upon ambulation, followed with marked hindlimb
weakness by 14–16 weeks of age, and seizures beginning at
4–6 weeks but rapidly increasing in frequency by 18–19 weeks.
Thus, by 18 weeks, all mice exhibitedmarkedly impaired forward
ambulation and frequent episodes of sustained seizures. Over
a range of 130–150 days postnatally, all of the 29 PBS treated
and 59 untreated control shiverer mice died, with median and
mean (±SEM) survivals of 135.0 ± 1.4 and 132.4 ± 2.1 days,
respectively.
In sharp contrast, of the 26 implanted mice, 20 died during this
period, but 6 (23.1%) survived. Whereas the average survival of
the untreated controls approximated 130 days, and none of the
88 total control mice survived to 150 days, these 6 implanted
mice survived over 160 days, and 4 appeared to have been
frankly rescued, surviving over a year before being sacrificed
for analysis. Remarkably, these mice exhibited overtly improved
neurological function, with decreased seizure incidence and im-
proved mobility and self-care. Transplanted mice surviving be-
yond 190 days exhibited apparent treatment-dependent cure,
with sustained survival over a year, accompanied by a virtually
complete recovery of normal neurological phenotype. As a result,
the engrafted mice as a group exhibited significantly prolonged
survival: Kaplan-Meier analysis (Hosmer and Lemeshow, 1999)
confirmed that the treatment-associated improvement in sur-
vival was statistically significant, and profoundly so (p =
0.0003; hazard ratio = 0.4718 (95% CI = 0.30–0.70) (Figure 1A).
Transplantation Was Associated with Neurological
Improvement and Diminished Seizures
The rescued mice exhibited substantial resolution of their neuro-
logical deficits. Shiverer mice typically exhibit truncal instability
and marked intention tremor, evident within weeks of birth,554 Cell Stem Cell 2, 553–565, June 2008 ª2008 Elsevier Inc.which becomes complicated by a progressive hindlimb weak-
ness, and multimodal sensory and perceptual deficits that in-
clude blindness, such that by 18–19 weeks of age they are se-
verely impaired (see Movie S1 available online). In addition,
they manifest a progressively worsening seizure disorder (Movie
S2), often succumbing to status epilepticus. Given the substan-
tially longer survivals noted in a fraction of the transplanted shiv-
erers, we askedwhat the behavioral concomitants were to trans-
plantation, as a function of time after cell delivery. We were
especially interested in any discernible differences in the behav-
ior or neurological status of shiverer mice that were rescued by
neonatal GPC transplant, relative to transplanted littermates
that nonetheless died. We noted that all of the shiverers, both
transplanted and controls, deteriorated identically over the first
several months after birth and transplantation. Indeed, up to
130 days, the point at which mice typically began to die in num-
ber, little difference was observed in the behaviors of trans-
planted relative to untransplanted shiverer mice. However, those
mice that survived the period spanning 130–150 days postnatally
exhibited noticeable improvement in their neurological exams
thereafter, frankly manifest by 7–8 months of age as diminished
frequency of seizures and improved ambulation, with more for-
ward motion and less retropulsion or freezing. Over the several
months thereafter, the transplanted mice incrementally im-
proved, regaining normal fluidity in ambulation and voluntary ex-
plorative behavior, and less truncal intention tremor. All five mice
surviving to at least 35weeks of agewere substantially normal by
that point and thereafter in terms of their grossly assessable neu-
rological function, save for a coarse axial intention tremor, man-
ifesting as a wobble on forward ambulation (Movie S3).
Because the death of most mice at 130–150 days of age was
coincident with the period of sharply increasing seizure activity,
we next assessed the frequency and duration of spontaneous
seizures in untreated and transplanted shi/shi 3 rag2 nulls, as
a function of age. We paid special attention to the incidence
of seizures in transplanted mice that were rescued by trans-
plant, compared with their treated counterparts that nonethe-
less succumbed. We found that the first seizures of shiverer
mice—typically characterized by absence-like episodes of
tonic akinesia, followed by a rapid evolution to brief tonic-clonic
events—appeared by 35–42 days of age (Figure 1B). At ap-
proximately 120 days, the incidence of seizures was noted to
substantially increase in treated and untreated animals alike.
Over the period spanning 120–140 days, the seizure incidence
of each group increased, yielding frequent seizures every hour
(see Figure S1 for a representative EEG recording); these ictal
events progressed to sustained periods of status epilepticus,
often associated with death. However, in those animals that
survived this period to enjoy long-term survival, seizure inci-
dence fell dramatically, such that no seizure activity whatsoever
was observed at 12 months (p < 0.0001 by one-way ANOVA,
separately comparing 12-month transplanted animal seizure in-
cidence to that of 4-month transplanted and control shiverers).
Thus, perinatal GPC transplantation was associated with mark-
edly diminished seizure activity in those shi/shi 3 rag2 null mice
that were rescued by perinatal transplantation, such that by
a year, none manifested any residual spontaneous seizure ac-
tivity, while otherwise exhibiting virtually complete neurological
recovery.
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Substantially Prolonged Survival
(A) Shiverer/rag2/ mice, either engrafted with
human glial progenitor cells (GPCs) at birth (n =
26, red), injected with saline (n = 29, green), or un-
treated (n = 59, blue) were maintained in small-
group housing and monitored daily until death.
The Kaplan-Meier survival graph, plotting the per-
centage of each group alive as a function of age in
weeks, shows that most mice die between 18 and
21 weeks. However, a fraction of engrafted mice
(n = 6, or 23.1%) lived substantially longer than
any control mouse; four survivedmore than 1 year,
at which point the experiment was terminated.
(B) Shiverer mice uniformly manifested a seizure
disorder that was typically apparent by 10 weeks
of age, and then worsened between 16 and 18
weeks. When seizure frequency was scored by
video with blinded post hoc assessment, trans-
planted and control shiverers both were noted to
seize frequently during weeks 18–21, correspond-
ing to the time span during which most mice died.
However, the seizure incidence among the trans-
planted shiverers fell thereafter, such that by 47
weeks of age, all surviving mice were seizure free.Besides spontaneous seizures, we noted that shiverers ex-
hibited stimulus-evoked seizure activity that increased in both
frequency and duration as a function of age. To quantify this
pathological response to handling, we established a brief
screening test by which mice were briefly and abruptly sus-
pended by the tail, and their behavioral responses observed.
We found that such tail suspension was sufficient to induce
seizures in a large proportion of shiverer mice, whether treated
or not, by 3 months of age. The induction of seizure activity
within 30 s of tail suspension was thus chosen as a metric
by which to assess the effect of cell transplant on seizure inci-
dence and duration. We observed that among the transplanted
shiverers, the percentage of individual tail suspension chal-
lenges resulting in clinically overt seizures rose to 75% ±
2.4% by 3–4 months. Among the transplanted mice that sur-
vived at least 5 months, 47% ± 2.8% of tail suspension chal-
lenges resulted in seizures. In contrast, by 8 months, none of
the four surviving mice could be induced to seize by tail sus-
pension. Linear regression of the percentage of mice induced
to seize, plotted against their age in days, revealed a best fit
of y = 0.324x + 116.7. Regression analysis confirmed that
the negative correlation between seizure incidence and age
(r = 0.826; r2 = 0.68) was significant (p < 0.0001; F = 53.68
[1, 25 df]) (see Figure S2).
Although these data do not yet allow us to causally attribute
the sustained survival of these transplanted shiverers to the
diminution of their seizure activity, the increased incidence of
spontaneous and stimulus-evoked seizures coincident with the
period during which most shiverers die, coupled with the
diminished seizure incidence of those transplanted survivors
that go on to survive (cf. Figures 1B and 1A), suggests that im-
proved seizure control contributes to the sustained viability of
the long-surviving transplant recipients.Perinatal Grafts of Human Glial Progenitors Yield
Widespread and Dense Host Myelination
To assess the terminal distribution of donor cells and robustness
of myelination in the transplanted animals, and to compare the
extent of donor cell dispersal and myelination between short-
and long-term survivors, the latter were ultimately sacrificed at
13 months of age, after assessment of their transcallosal con-
duction velocities and seizure frequency. The brains and spinal
cords of these mice were then analyzed in terms of donor cell
distribution and density; myelin production and the proportion
of myelinated axons; nodal architecture and reconstitution; and
ultrastructural metrics, including myelinated axons and myelin
G ratios. Each of these metrics was then compared to those
obtained from transplanted mice that had died earlier, as well
as to unimplanted shiverer controls and wild-type, normally
myelinated, rag2 null mice.
These histological data supported the compelling nature of the
survival data. Human donor-cell engraftment was extraordinarily
extensive, with essentially whole neuraxis penetration and colo-
nization by the human GPCs (Figure 2A). High donor-cell densi-
ties were observed throughout the forebrain, cerebellum, brain-
stem, and cervical spinal cord, diminishing only at the level of the
thoracolumbar cord, yet increasing again in the sacral cord and
conus medullaris. The pattern of myelination, as indicated by
MBP expression, reflected this widespread engraftment, with
equally widespread and dense myelination (Figures 2B–2F), in-
cluding not only all major central white matter tracts but also
structures as distant and diverse as the cranial ganglia, optic chi-
asm, and conus medullaris (e.g., Figure 2G). These long-term
survivors, whose neurological exams had largely normalized by
9 months of age, exhibited essentially complete myelination of
the brain, brainstem, and cerebellum, with substantial myelina-
tion of the optic nerves (Figure 2B), spinal cord (Figure 2E), andCell Stem Cell 2, 553–565, June 2008 ª2008 Elsevier Inc. 555
Cell Stem Cell
Cell Therapy Rescue of a Congenital LeukodystrophyFigure 2. Perinatal Grafts of Human Glial Progenitors Yield Widespread and Dense Host Myelination
(A and B) Serial sagittal images of an engrafted shi/shi 3 rag2/ brain, sacrificed at 1 year of age. Each image in (A) and (B) represents a montage of 50–100
images at 103. Each series begins 750 mm lateral to the midline and continues at 600 mm intervals. (A) Human donor cells, immunolabeled in 14 mm
cryosections using an antihuman nuclear antibody (hN; red). (B) Alexa 488-labeled myelin basic protein (MBP; green) in sections adjacent or nearly so to their556 Cell Stem Cell 2, 553–565, June 2008 ª2008 Elsevier Inc.
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(Figures 3A–3C). In regards to the latter, the cessation of donor
GPC migration at the border of CNS and PNS was striking,
such that donor-derived myelination occurred up to, but not be-
yond, the transition points demarcating central ganglia and roots
from peripheral nerve (Figures 3A–3E). The resultant densities
and patterns of donor cell dispersal resulted in the virtually com-
plete chimerization of themurine hosts’ central nervous systems,
which thereby acquired a largely humanizedwhitematter. Three-
dimensional reconstructions confirmed that both the pattern and
density of donor-derived myelination in the brains of trans-
planted shiverers approximated that of wild-type, normal mice.
Xenografted Shiverer Brains Exhibit Restored
Nodes of Ranvier
We next asked if donor cell-derived myelination of shiverer
axons was accompanied by the acquisition of normal nodes of
Ranvier and paranodal structure (Figures 4A–4D). Using high-
resolution confocal imaging of the corpus callosa, cervical spinal
cords, and optic nerves of implanted shiverers killed at 35 or 52
weeks of age, we assessed the distribution pattern of the para-
nodal and juxtaparanodal proteins Caspr and the KV1.2 volt-
age-gated potassium channel, respectively—the contiguous
interaction of which characterizes the normal node of Ranvier
(Rasband and Trimmer, 2001; Schafer and Rasband, 2006).
These potassium channels are assembled at—and functionally
define—the juxtaparanodes in myelinated axons, but they are
broadly and nonspecifically expressed in unmyelinated fibers
(Rasband and Trimmer, 2001). In addition, we determined the
axonal expression and compartmentalization of NaV1.6 fast
sodium channels, which are typically sequestered at nodes of
Ranvier in intact myelinated axons but dispersed broadly along
unmyelinated or dysmyelinated fibers. Similarly, we immuno-
stained for bIV spectrin, which couples to ankyrin to organize
fast sodium channels at the node of Ranvier, and hence typically
coincides with nodal Nav1.6 expression (Schafer and Rasband,
2006; Sherman and Brophy, 2005; Yang et al., 2007).
Using these complementary nodal markers, we identified an
essentially normal organization of the nodes of Ranvier in trans-
planted mice, which was indistinguishable from that of wild-type
mice. Caspr and KV1.2 were expressed in organized paranodal
and juxtaparanodal apposition, with an expression pattern that
contrasted sharply with the grossly uncoordinated pattern of dif-
fuse Caspr and KV1.2 immunolabeling that was evident in the un-
transplanted controls (Figures 4A–4D). Similarly, both NaV1.6
(Figures 4A00–4D0) and bIV spectrin (Figures 4A00–4D00) clearly
identified nodes of Ranvier in the transplanted shi/shi mice,
flanked by Caspr defining the paranodes; their untransplanted
controls showed no such sequestration of either NaV1.6 or bIV
spectrin expression. Together, these observations suggest that
despite interspecies chimerization, the glioaxonal interactionsof human GPC-derived oligodendrocytes with host mouse
axons were functionally appropriate. More broadly, they indicate
that GPC-derived oligodendrocytes are able to communicate
effectively with host axons, organizing structurally appropriate
nodes of Ranvier while sequestering fast sodium channels within
the nodes, and thereby myelinating their axonal substrates
effectively and appropriately.
Transcallosal Conduction Velocities Are Restored
in Xenografted Shiverer Brains
In light of the apparent histological reconstitution of normal my-
elin, we next asked if donor OPC-derived myelin was sufficient in
extent and functional competence to restore the conduction
speed of newly myelinated central axons. To this end, we as-
sessed the conduction velocity across the corpus callosum in
a sample of four long-surviving transplanted shiverer mice
12–13 months after neonatal xenograft. The transcallosal nerve
conduction velocities were determined by recording response
amplitudes and times from depth electrodes placed bilaterally
in the corpus callosa of each of these mice, after contralateral
stimulation at symmetric sites during open craniotomy. Equal
numbers of age-matched wild-type (congenic C3H) mice and
rag2 null controlswere assessed identically, aswas a necessarily
younger (4months old) sample of untransplanted shiverer3 rag2
null mice. As this was a terminal procedure, these animals—all of
which had exhibited not only sustained survival but also a sub-
stantial restoration of normal neurological function—were sacri-
ficed after measurement of their transcallosal conduction veloc-
ities, thus ending the survival study in which they were subjects.
We found that though control Fvb wild-type (n = 3) and rag2
null C3H mice (n = 4) exhibited conduction velocities of 0.324 ±
0.01 and 0.328 ± 0.03 m/sec respectively, the shiverer 3 rag2
mice (n = 4), also on the C3H background, exhibited substantially
slower conduction, at 0.260 ± 0.02m/sec (Figure 4E). In contrast,
transplanted shiverer 3 rag2/ mice, tested just prior to
sacrifice 12–13 months posttransplant (n = 3), had an average
conduction velocity of 0.330 ± 0.01 m/sec. Repeated-measures
ANOVA with post hoc Boneferroni t tests revealed a significant
treatment effect (F = 35.15 [3, 9 df]), such that callosal conduc-
tion by the transplanted mice was significantly faster than
untransplanted shiverer3 rag2/mice (p < 0.001), and indistin-
guishable from that of normally myelinated Fvb wild-type and
rag2 null mice. The more rapid transcallosal conduction
exhibited by the transplanted mice was sustained across stimu-
lus intensities, and thus appeared to represent improved con-
duction across a wide spectrum of fiber diameters (Figure 4F).
Thus, neonatal transplantation of human OPCs yielded sufficient
myelin, in terms of both density and physiological competence,
to restore normal interhemispheric conduction velocity to amajor
central tract, the corpus callosum.matched sections in (A). All major white matter tracts, including those of the corpus callosum, capsules, striatum, fimbria, cerebellum, and brainstem heavily
express MBP.
(C–G) Black-and-white images of MBP-immunoreactive fibers in a number of sites reveal high-efficiency axonal myelination; all images of transplanted shi/shi3
rag2/ mice at >1 year posttransplant. (C) The rostral striatum, corpus callosum, and neocortical layers 5 and 6 are shown in sagittal section. (D) Higher mag-
nification of (C) shows the MBP-defined myelination of individual fibers within the striatum, as well as the larger bundles of corticostriatal and striopallidal fibers.
(E) Donor-myelinated MBP+ fibers in a longitudinal section of the cervical spinal cord; dorsal column to the left, central gray to the right. (F) Interwoven donor-
myelinated fibers of the brainstem, in the pontine base. (G) Donor-derived MBP in the conus medullaris; exiting myelinated roots of the cauda equina to the left.
Scale bars: 2.5 mm in (A) and (B), 200 mm in (C), 40 mm in (D), 50 mm in (E), 60 mm in (F), and 125 mm in (G).Cell Stem Cell 2, 553–565, June 2008 ª2008 Elsevier Inc. 557
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Cell Therapy Rescue of a Congenital LeukodystrophyFigure 3. Transplanted GPCs Invade the Cranial and Spinal Roots but Obey the CNS-PNS Border
Transplanted mice exhibited robust myelination throughout the entire CNS neuraxis by 9 months of age, that included not only the brain, brainstem, cerebellum,
and spinal cord, but also the cranial nerves, ganglia, and both cranial and spinal roots (see Figures 2 and 4). Of note, the invasion of human glial progenitor cells, all
derived from the fetal forebrain, was sharply delimited to the CNS, with no invasion whatsoever of the peripheral nerves beyond the root takeoffs.
(A and B) Dense concentration of human donor cells (antihuman nuclear antigen, red) in the trigeminal ganglion (TG) and the concurrent prohibition of donor cell
infiltration into the trigeminal nerve (nV), a peripheral nerve. Accordingly, donor-derived myelin (MBP, green) was limited to the ganglion and trigeminal nerve
takeoff, and did not extend into nV proper.
(C) A wider field color composite of (A) and (B), which correspond to the boxed area of (C), further demonstrating that the transplanted GPCs strictly respect the
CNS-PNS border. In contrast, (D) and (E) show an adjacent section stained for the peripheral myelin protein P0 (blue) and for either human nuclear antigen (red) or
central myelin basic protein (green). The human cells are seen to have stopped at the P0 protein-defined threshold to the PNS. Scale bar: 50 mm.Myelination and Axonal Ensheathment
Were Progressive over Time
We had previously established that the dispersal of donor cells
following neonatal implantation of human GPCs was relatively
rapid, with the terminal distributions of engrafted progenitors oc-
curring within 4–8 weeks of neonatal administration, and myeli-
nation proceeding over the several months thereafter (Windrem
et al., 2004). In the present study, given the extended survival
of mice transplanted both in brain and brainstem, we were
able to assess the later progression of myelination in the graft re-
cipients. We asked whether myelination continued to progress
even after extended survival had been achieved. To that end,
we examined the brains of transplanted shiverers at 18–20 (n =
10), 27 (n = 1), 35 (n = 1), and 52–56 (n = 4) weeks of age, and as-
sessed the distribution pattern and densities of human donor
cells, as well as of donor-derived myelin, in these recipient
brains. (The 20-week-olds had died natural deaths despite their558 Cell Stem Cell 2, 553–565, June 2008 ª2008 Elsevier Inc.extensive donor cell engraftment, whereas the 52- to 56-week-
olds were long survivors, which had been killed to allow histolog-
ical analysis. The deaths of the 27- and 35-week-old mice (natu-
ral and accidental deaths, respectively) provided informative, if
singular, intermediate time points.
We found that though cerebral and cerebellar myelination, as
followed by MBP expression, were substantial and geographi-
cally widespread at 20 weeks, both the density and distribution
of MBP expression in the brainstem and cervical spinal cord
were more extensive at 35 weeks than 20, and much more so
at 52–56 weeks (Figures 5A–5C and 5D–5F). In particular, the
52- to 56-week-old transplantedmice exhibited essentially com-
plete myelination of the brainstem (Figure 5C; also Figure 2B),
whereas the 20-week-olds still exhibited a number of regions
of relative hypomyelination relative to wild-type controls
(Figure 5A). The areas of relatively delayed myelination included
the ventral long tracts of the brainstem, as well as the brainstem
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Cell Therapy Rescue of a Congenital LeukodystrophyFigure 4. Engrafted shi/shi Brains Exhibit Restored Nodes of Ranvier and Callosal Conduction Velocities
The expression patterns of several antigens characteristic of nodes of Ranvier, including nodal (NaV1.6, bIV-spectrin), paranodal (Caspr) and juxtaparanodal
(KV1.2) proteins, were investigated in the spinal cord ([A–D] and [A
0–D0]) and optic nerves (A00–D00) of normally myelinated wild-type (rag2/) mice (A–A00), and
compared to the corresponding expression patterns in the optic nerves of both untreated (B–B00), and transplanted ([C–C00] and [D–D00]) shiverer 3 rag2/
mice. The nodal architecture of the transplanted shiverers was indistinguishable from that of wild-type controls for every antigen tested; both exhibited the so-
dium channel and spectrin clustering, flanked by the paranodal Caspr and juxtaparanodal Kv1.2, of mature nodes. The nodal integrity of the transplanted shiv-
erers ([C–C00]and [D–D00]) contrasted sharply to the disorganized and indistinct antigen expression patterns of the untreated mice (B–B00), in which neither nodal
channel clustering nor paranodal Caspr sequestration was noted. (E and F) Transcallosal responses were evoked by electrical stimulation in mice in vivo. (E)
Ttranscallosal conduction velocities obtained from wild-type, rag2/, shiverer 3 rag2/, and transplanted shiverer 3 rag2/ mice, all assessed between
12 and 13 months after neonatal transplant. (F) Relationship between stimulus intensity and signal amplitude in C3H wild-type mice, rag2/ mice, shiverer 3
rag2/ mice, and transplanted shiverer 3 rag2/ mice, respectively.tegmentum and intrinsic internuclear tracts, all of which were
more extensively myelinated at 52 weeks of age than at earlier
time points. By scoring the proportion of ensheathed host axons
in confocal optical sections immunostained for MBP and neuro-
filament, we found that by 52 weeks, 78.0% ± 4.8% of axons in
the cervical corticospinal tract at the cervicomedullary junction
were myelinated (Figure 5H), a marginally smaller proportion
than that observed in wild-types (93.9% ± 0.9%). By that time
point, the proportion of myelinated axons in the corpus callosum
of the transplanted animals was similarly indistinguishable from
that of the wild-type controls; each exceeded 60% (Figure 5G).
We next used transmission electron microscopy (TEM), concen-
trating on the longitudinal and largely parallel fibers of the cervi-
cal spinal cord, to validate the criteria by which we defined
myelin-ensheathed axons in our confocal analysis. TEM of the
cervical corticospinal tract of 12- to 13-month-old transplanted
shiverers established that themajority of axonsmanifested ultra-
structurally normal myelin, with both major dense lines and mul-
tilayer lamination (Figures 5I and 5K), thereby confirming that
axons appearing ensheathed in confocal optical sections were
indeed so. Furthermore, the major dense lines of the observed
myelin indicated its necessarily donor cell origin, as shiverer
oligodendrocytes do not make major dense lines; formation of
the latter requires myelin basic protein, in which shiverers aregenetically deficient (Readhead et al., 1990). In addition, the cal-
culated G ratio, defined as the ratio of axonal diameter to total
myelin-ensheathed fiber diameter, was significantly higher in
the untreated shiverers than in either transplanted shiverers or
wild-type rag2 nulls; the latter groups did not differ from one an-
other (Figure 5L). This indicated that whereas untreated shiverers
had little or no myelin ensheathment, their transplanted kindreds
had myelin sheaths as thick, on average, as their normally mye-
linated wild-type 3 rag2 null controls.
The progressive myelination of transplanted shiverers did not
appear to be a function of the rate or kinetics of donor cell dis-
persal, in that the topography of donor cells at 35 weeks did
not differ substantially from that observed at 52 weeks. Nonethe-
less, the local densities of donor-derived cells did appear to rise
over time; this rise was asymptotic (Figure 6A), which appeared
to reflect the fall in mitotic competence of the donor cell pool fol-
lowing their initial expansion in the first half-year or so after trans-
plantation (Figure 6B). These data suggest that long after human
donor cells achieve their destinations, myelinogenesis and axo-
nal ensheathment continue to progress slowly, ultimately achiev-
ing themyelinationof the recipient neuraxis onlyafter aprotracted
period of postnatal maturation; this may reflect the incremental
engagement of local axons by single oligodendrocytes, as the
latter mature and expand their individual domains of myelinCell Stem Cell 2, 553–565, June 2008 ª2008 Elsevier Inc. 559
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Cell Therapy Rescue of a Congenital LeukodystrophyFigure 5. Myelination and Axonal Ensheathment Were Progressive over Time
(A–C) Sagittal sections of hGPC-implanted mice immunolabeled for MBP (green) at (A) 20 weeks; (B) 35 weeks; and (C) 52 weeks. (A) Major white-matter regions
of the brain, including the corpus callosum, fimbria, optic tract, and both the cerebral and cerebellar peduncles, are already myelinated at 20 weeks. (B) At 35
weeks, the area of dense myelination has expanded into the midbrain and hindbrain. (C) By a year, myelin was well distributed, and myelination appeared
complete, throughout the forebrain and hindbrain, including the lowers layers of neocortex, the colliculi, the pons and medulla, and the major corticopontine
and corticospinal tracts.
(D–F) Corresponding confocal optical sections of transplanted shiverer mouse corpus callosum taken at (D) 20, (E) 35, and (F) 52 weeks, immunolabeled for
neurofilament (red) and MBP (green), reveal the progressive increase in axonal ensheathment with time.
(G and H) The proportion of MBP-ensheathed axons, as determined by confocal analysis, in the (G) corpus callosa (CC) and (H) cervical corticospinal tracts of the
spinal cord (SC) in 1-year-old transplanted shi/shi 3 rag2/ mice compared to both untreated and wild-type rag2/ controls. At both sites, most axons in the
transplant recipients were ensheathed by MBP-defined myelin. In contrast, no ensheathment was noted in their untreated counterparts.
(I–K) Electronmicrographs of spinal cord cross-sections in (I) untreated shi/shi3 rag2/mice, (J) wild-type rag2/ controls, and (K) 1-year-old transplanted shi/
shi 3 rag2/. (L) G ratios calculated in 1-year-old implanted shiverers, compared to their wild-type and untreated shiverer controls. The correlation between
myelin sheath thickness and axonal diameter in implanted mice is indistinguishable from that of wt/rag2 null mice, whereas myelin sheaths are virtually undetect-
able in untreated shiverers. Scale bars: 2.5 mm in (A)–(C), 10 mm in (D)–(F), and 1 mm in (I)–(K).ensheathment, adding axons to their ensheathed cohort one
at a time over a period of many months.
Long-Term Survival Was Associated with Humanization
of the Recipient White Matter
The selective expansion of the human glial population in the shiv-
erer mouse white matter appears to be at least in part a product
of the more sustained proliferation of the transplanted human560 Cell Stem Cell 2, 553–565, June 2008 ª2008 Elsevier Inc.GPCs (Figures 6B and 6D), which as derived from the late sec-
ond-trimester fetal SVZ, would be expected to have continued
actively dividing for at least another 9–12 months, assuming
cell-autonomous regulation of expansion potential. Accordingly,
when we plotted the number of all-human cells in the recipient
mouse brains, as a function of time, we found that the initial
dose of 300,000 cells per recipient had expanded to an average
of 12 million human donor glia by 12–14 months in the long-term
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Cell Therapy Rescue of a Congenital Leukodystrophysurvivors (Figure 6A). When the incidence of Ki67+ cells was as-
sessed in three sample regions—the corpus callosum, fimbria,
and cerebellar whitematter—the fraction of mitotic human donor
cells was found to be much higher than that of the local host
cells, both perinatally and for many months thereafter; only at
a year after engraftment was the Ki67+ fraction of human donor
cells observed to fall below 2% (Figure 6B). Even then, the frac-
tion of Ki67+ human glia remained higher than the corresponding
proportion of Ki67+ mouse cells, in both the transplanted hosts
and in the rag2 wild-type or shi/shi 3 rag2/ mouse controls
(F = 12.42 [3, 2 df] by two-way ANOVA permuting cell type and
region; p < 0.05 for each comparison, by Boneferroni posthoc t
tests) (Figure 6D). Ultimately, despite the preferential expansion
of the human donor cell pool, its relative mitotic quiescence was
achieved by a year after transplantation, according to the ap-
proximate time course by which normal human GPCs attenuate
their expansion in situ. No evidence of heterotopic foci, anapla-
sia, or neoplastic transformation was noted in over 100 trans-
planted mice serially examined.
These data indicate that donor human GPCs exhibit more
robust and sustained mitotic expansion than their host murine
counterparts after transplantation and that, over time, this results
in the relative humanization of the recipient white matter. Indeed,
quantification of the human donor cell complement revealed that
in four long-surviving transplanted mice sacrificed at 12–14
months, at least one-third of all cells in the corpus callosum, fim-
bria, and cerebellar white matter were of human origin (35.3% ±
11.8%, 42.9% ± 10.9%, and 40.8% ± 6.9%, respectively)
(Figure 6C). In three of the four, over 40% of all cells in each of
these white matter regions were human, and in the densest en-
graftment among these—that of a mouse sacrificed at 13
months—54.6% of all cells in its callosumwere human. Because
just under one- third of all cells in the shiverer white matter are
nonglial (unpublished data)—these includemicroglia, endothelial
cells, and pericytes—we estimate that at least 80% of all callosal
glial cells in this ‘‘best case’’mousewereof humanoriginbya year
after engraftment; more broadly, over half of all callosal glia were
human in each of the long-surviving recipients assessed.
DISCUSSION
In these experiments, we delivered highly enriched isolates of
human glial progenitor cells into neonatal shiverer 3 rag2 null
(shi/shi 3 rag2/) immunodeficient and myelin-deficient mice,
using a multifocal delivery strategy that achieved both wide-
spread and dense donor cell engraftment throughout the recip-
ient CNS. Our injection sites were chosen so as to permit contig-
uous infiltration of migrating donor cells into all major brain,
brainstem, and spinal white-matter tracts, without hindrance
from intervening gray matter structures that might delimit the
migration and sustained multilineage competence of engrafted
glial progenitor cells (Windrem et al., 2002). By this strategy,
we achieved the complete, whole-neuraxis myelination of the
engrafted hosts; in a fraction of these animals, this resulted in
the effective rescue of this otherwise lethal phenotype. These
mice exhibited essentially complete myelination of the brain,
brainstem, and cerebellum, with substantial myelination of the
optic nerves, cranial roots and ganglia, spinal cord, and spinal
roots, that was associated with clinical rescue, as reflected bysustained survival and substantially restored functional compe-
tence—the latter as manifested electrophysiologically and
behaviorally.
This transplant-associated reduction in morbidity and mortal-
ity was accompanied by the acquisition of normal nodes of
Ranvier and paranodal structure, a restitution of transcallosal
conduction velocity, ultrastructurally normal and complete mye-
lination of the overwhelming majority of axons, and a restoration
of a substantially normal neurological phenotype. These trans-
plants were also attended by a virtually complete chimerization
of the recipient central nervous system, such that the surviving
recipients, and in particular the long-term survivors, developed
a largely humanizedwhitematter. Donor cell expansion occurred
in an asymptotic fashion, such that chimerization evolved over
the 8–9 months after transplantation, with progressive myelina-
tion reflecting ongoing axonal ensheathment as much as persis-
tent cell expansion.
The progressive chimerization of the host white matter with
admixed human donor cells was attended by a significant loss
of host glial progenitor cells and oligodendroglia (data not
shown). Whether the competitive strength of the human donor
cells was the result of more effective axonal interactions by mye-
linogenic donor cells relative to nonmyelinogenic host progeni-
tors, or rather reflected the selective mitotic expansion of the hu-
man donor cells in the postnatal murine environment, or even the
selective geographic displacement of the host cells by their do-
nor-derived counterparts, is unclear; it seems likely that each of
these factors contributed to the marked competitive advantage
of the human donor cells. Yet setting aside the nature of this do-
nor-host competition, the degree of the resultant humanization
was remarkable: by 13 months of age, over one-third of all cells,
and the majority of the glial cells within the recipient callosa, fim-
bria, cerebellar white matter, and cervical spinal cords—indeed,
in every region quantified—were human. Moreover, of the recip-
ient axons in these regions, >60%were successfully ensheathed
by donor oligodendrocytes; the nodal architecture of the resul-
tant chimerized brains was thus established by human myelin-
associated proteins. As a result, multifocal neonatal delivery of
human glial progenitor cells to myelin-deficient immunodeficient
mice—intended initially as a proof of principle of a promising
therapeutic approach—has also provided us mice with largely
humanized white matter (Figures 6E and 6F), in which the
responses of human glial oligodendrocytes and astrocytes to
injury and disease may now be observed in real time, in vivo.
This may prove an invaluable experimental model going forward,
apart from the value of somatic chimerization via progenitor cell
allografts as a potential therapeutic approach in the dysmyelinat-
ing disorders.
Several reports have noted the potential utility of neural stem
or progenitor cell grafts in alleviating pathology in congenital leu-
kodystrophies associated with lysosomal storage disorders;
these efforts have capitalized on the provision of wild-type en-
zyme by engrafted donor cells to the otherwise deficient host
cells with which they structurally integrate (Lee et al., 2007;
Pellegatta et al., 2006; Snyder et al., 1995). Yet no cell-based
treatment of any congenital hypomyelination has ever proven
sufficient to rescue the underlying phenotype. A number of
previous studies demonstrated that transplants of fetal tissue
(Lachapelle et al., 1983), tissue dissociates (Gumpel et al.,Cell Stem Cell 2, 553–565, June 2008 ª2008 Elsevier Inc. 561
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Cell Therapy Rescue of a Congenital LeukodystrophyFigure 6. Long-Term Survival Was Associated with Humanization of the Recipient White Matter
(A) Perinatally transplanted humanGPCs increase in number asymptotically over the course of a year. From an initial dose of 300,000 on postnatal day 1, the cells
increase to an average of 12 million/brain by 1 year posttransplantation (y = 9,898,000 + 733,632x + (5709)2 ; r2 = 0.83).
(B) By 1 year, donor cells comprised over 40% of all cells in the fimbria and cerebellar white matter, and over one-third in the corpus callosum. Because
the total cell count includes host vascular cells and microglia, the human donor-derived cells appeared to comprise a net majority of all glial cells
by that stage.
(C) Over the year after implantation, the rate of human GPC proliferation in white matter declined exponentially (red; y = 14.013e0.0475x; r2 = 0.79). At 8 weeks,
12.35% of human GPCs in the mouse corpus callosum are Ki67+, but by 1 year, an average of 1.22% are Ki67+. From 5 to 12 months, the percentage of Ki67+
mouse cells in the corpus callosum of untreated rag2 null mice also declines exponentially, but beginning at a lower rate (purple; y = 2.9154e0.0497x; r2 = 0.83).
The Ki67+ percentages of endogenous mouse cells in the same sections of transplantedmice fromwhich the hGPC percentages were obtained, however, do not
follow a pattern of exponential decline (blue; y = 1.3684e0.02 3 r2 = 0.1855).
(D) At 1 year, the percentage of hGPCs in white matter that are Ki67+ (red) exceeds that of the endogenous mouse cells in the same mice (blue), as well as that of
untreated rag2 null mice (yellow) and 4-month-old untreated shiverer/rag2 homozygotes (green) in corpus callosum, fimbria, and cerebellum.562 Cell Stem Cell 2, 553–565, June 2008 ª2008 Elsevier Inc.
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Cell Therapy Rescue of a Congenital Leukodystrophy1987, 1989), neural stem cells (Mitome et al., 2001; Yandava
et al., 1999), and embryonic stem cell-derived glia (Nistor et al.,
2005) could give rise to myelinogenic oligodendrocytes in the
shiverer mouse, as well as in other animal models of hypomyeli-
nation, including the myelin-deficient rat (Archer et al., 1994;
Hammang et al., 1997) and shaking pup (Archer et al., 1997).
However, none of these efforts yielded sufficiently abundant or
extensive myelination to provide significant survival or long-
term functional benefit to the treated recipients. In contrast,
our present results suggest the feasibility of an outright rescue
of the disease phenotype, using highly enriched preparations
of human glial progenitor cells delivered to multiple sites of the
neonatal neuraxis, at relatively high cell-dose levels.
Only a minority of the transplanted shiverers were rescued by
neonatal transplantation. Amajor challenge going forward will be
to better define the critical sites that need to be rapidly myelin-
ated to avoid death, and hence allow progressive myelination
to ultimately assuage disease progression. Our results suggest
that early myelination of the brainstem, and an early transplant-
associated diminution in seizure activity, are both associated
with clinical rescue; as such, future studies may combine antiep-
ileptic treatment with more posteriorly biased progenitor grafts,
as a potential strategy to improve the likelihood of clinical rescue.
These caveats aside, our results indicate that multifocal perinatal
transplantation of human glial progenitor cells can be sufficient
to rescue a congenital lethal hypomyelination. The sustained vi-
ability and restored functional competence of these animals au-
gers well for the potential utility of this approach in the treatment
of precociously apparent leukodystrophies, in particular those
hypomyelinating disorders manifesting neonatally, such as Peli-
zaeus-Merzbacher disease (PMD; Garbern and Hobson, 2002;
Nave and Griffiths, 2004; Powers, 2004). The pathological simi-
larity of PMD, an X-linked misexpression of proteolipid protein,
to the periventricular leukomalacia of cerebral palsy (Deguchi
et al., 1997; Rezaie and Dean, 2002; Volpe, 2001), suggests
the potential applicability of this glial progenitor cell-based treat-
ment strategy to a wide range of hereditary and ischemic (Back
et al., 2001) childhood disorders of myelin.
EXPERIMENTAL PROCEDURES
Cells
Fetal GPCs were extracted from second trimester human fetuses (19–22
weeks gestational age [GA]), obtained at abortion as described (Windrem
et al., 2004). The forebrain ventricular/subventricular zones were dissected
from the remaining brain parenchyma, the samples chilled on ice, and the
minced samples then dissociated using papain/DNase as described (Keyoung
et al., 2001), always within 3 hr of extraction. The dissociates were maintained
overnight in minimal media of DMEM/F12/N1 with 20 ng/ml FGF. A total of five
tissue samples (one at 19 weeks GA, one at 20 weeks, and three at 22 weeks)
were used for this study, all from chromosomally normal fetal donors. All sam-
ples were obtained with consent under approved protocols of the University of
Rochester, Cornell/New York Presbyterian Hospital, and Albert Einstein
College of Medicine/Jacobi Hospital Institutional Review Boards.Sorting
Glial progenitor cells were isolated from dissociated tissue using a dual immu-
nomagnetic sorting strategy. On the day after dissociation, the cells were incu-
bated with mouse anti-PSA-NCAM (Chemicon) at 1:100, then washed and la-
beled with microbead-tagged rat antimouse IgM (Miltenyi Biotech), and
removed by MACS depletion. The remaining PSA-NCAM cells were next in-
cubated 1:1 with mAb A2B5 supernatant (clone 105; ATCC, Manassas, VA) for
20 min, then washed and labeled with microbead-tagged rat antimouse IgM
(Miltenyi Biotech). All incubations were done on ice (Keyoung et al., 2001;
Roy et al., 2000). Magnetic separation of A2B5+ cells (MACS; Miltenyi) was
then performed, as described (Nunes et al., 2003). The bound cells were
then eluted, yielding a highly enriched population of A2B5+/PSA-NCAM cells.
After sorting, the cells were maintained in vitro for 1–2 days in DMEM/F12/N1
with 20 ng/ml bFGF, then frozen and stored in liquid nitrogen at 23 106 cells/ml
in 7% DMSO/93% FBS.
Transplantation and Husbandry
Homozygous shiverers were crossed to homozygous rag2 null immunodefi-
cient mice (Shinkai et al., 1992) to generate a line of shi/shi 3 rag2/ mye-
lin-deficient, immunodeficient mice. Newborn pups of this line were trans-
planted within a day of birth, using a total of 300,000 donor cells dispersed
over five injection sites. The pups were first cryoanesthetized for cell delivery,
and then 53 104 donor cells in 0.5 ml HBSS were injected at each of four loca-
tions in the forebrain subcortex, specifically into the anterior and posterior an-
lagen of the corpus callosum bilaterally. These injections were delivered to
a depth of 1.0–1.2 mm ventrally, depending on the weight/size of the pup
(which varied from 1 to 1.5 g). A fifth injection of 105 cells in 1 ml was delivered
into the cerebellar peduncle dorsally, to gain access to the major cerebellar
and dorsal brainstem tracts. All cells were injected through pulled glass pi-
pettes, inserted directly through the skull into the presumptive target sites.
The pups were then returned to their mother, until weaning at 21 days; at
that point, each litter was moved to separate housing. After weaning, mice
were checked at least twice daily. Mice that died from immediate surgical
complications or before weaning (two saline injected and one GPC trans-
planted) were excluded from the experiment. Typically as of 130 days of
age, mice in all groups began to die. They were checked several times daily,
and if found so moribund as to be unable to right themselves upon being
moved, they were given barbiturate anesthesia, then perfusion fixed with
HBSS followed by 4% paraformaldehyde. When mice were instead found
dead, their brains were removed and postfixed for 2 hr in cold paraformalde-
hyde.
Survival Analysis and Statistics
Kaplan-Meier analysis was used to assess the different survivals of trans-
planted and control mice, as described (Hosmer and Lemeshow, 1999). No dif-
ference in survival was observed between saline-injected and untreated mice,
so the two populations were combined as a single control population for the
Kaplan-Meier comparison with GPC-implanted mice.
Analyses of variance (ANOVA) were performed usingGraphPadPrism (v4.0c
for Macintosh; GraphPad Software, San Diego, CA).
Immunolabeling
Human cells were identified with mouse antihuman nuclei, clone 235-1 at
1:100 (MAB1281, Millipore, Billerica, MA). Myelin basic protein was labeled
with rat anti-MBP at 1:25 (Ab7349, Abcam, Cambridge, MA), and axons with
mouse antineurofilament cocktail at 1:1000 (SMI-311 and SMI-312, Covance,
Princeton, NJ). Monoclonal antibodies against Caspr, Nav1.6, and Kv1.2 were
used at 1:600, 1:200, and 1:200, respectively, and were obtained from Neuro-
Mab (Davis, CA). Rabbit anti-Caspr and anti-bIV spectrin were generated as
described (Rasband and Trimmer, 2001; Yang et al., 2007); rabbit anti-Caspr2(E and F) Progressivemyelination (MBP, green) ofmouse axons (neurofilament, in red) was attended by chimerization of the recipient whitematter, such that by 20
weeks, host cells (DAPI, blue) are exceeded by human donor cells (human nuclear antigen, hNA, purple, as blue colabeled with hNA, red). (E) Parasagittal section,
including dorsal callosum and overlying cortex of a transplanted shiverer at 20 weeks, showing human donor-derived myelination of callosum and admixture of
host (blue, DAPI) and donor cells (purple, as blue colabeled with hNA, red). Both myelinated (MBP, green) and unmyelinated (NF, far red) fibers are evident tra-
versing lower cortical layers. (F). Higher magnification section through fimbria of hippocampus, showing myelinated fibers viewed en face, with admixed mouse
(blue) and human (purple, representing blue colabeled with hNA, red) cells. Scale bars: 100 mm in (E) and 50 mm in (F).Cell Stem Cell 2, 553–565, June 2008 ª2008 Elsevier Inc. 563
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(Ab33427) and used at 1:1500. Alexa Fluor secondary antibodies, goat anti-
mouse, rat, and rabbit 488, 568, 594, and 647 were used at 1:400 (Invitrogen,
Carlsbad, CA).
Myelinated Axon Counts
Uniform random sagittal sections of the cervical spinal cord and coronal sec-
tions of the corpus callosum were selected for neurofilament and MBP stain-
ing; in the spinal cord samples, the most medial sections were analyzed with
respect to the percentage of myelinated host axons. A 1 mm stack of 10 super-
imposed optical slices taken at 0.1 mm intervals (Olympus FluoView 300) was
made for each of three fields of view in the dorsal columns, beginning rostrally
and progressing caudally. Three parallel, equidistant lines were laid over the
images perpendicular to the axons. Axons were scored at intersections with
the lines as either myelinated (closely apposed to MBP on both sides) or un-
myelinated. This procedure was then repeated for the coronally cut samples
of corpus callosum.
Proportionate Representation of Donor Cells
The percentage of human cells in the recipient white matter was assessed as
a function of time after transplantation. Randomly initiated, uniformly sampled
sagittal sections of the brains were labeled for human nuclei and DAPI (Vector
Labs). Four to six sections (depending on the persistence of the structure in the
selected range of sections) of the corpus callosum, fimbria, and cerebellar
white matter were counted, with data entry and reconstruction using Bio-
Quant. All human nuclei and DAPI-labeled cells in the white matter regions
of these 14 mm sections were counted.
Electron Microscopy
The four mice that survived over a year were perfused transcardially with
HBSS, followed by 4% paraformaldehyde with 0.25% glutaraldehyde and
6% sucrose in phosphate buffer (sucrose PB). One hemisphere of each brain
and longitudinal half of each spinal cord were postfixed in 2% paraformalde-
hyde, 2.5% glutaraldehyde in sucrose PB for electron microscopy; the other
half of each brain and spinal cord were postfixed in 4% paraformaldehyde in
sucrose PB for immunohistochemistry. Tissue samples used for electron mi-
croscopy were osmicated, dehydrated in ethanol, and embedded in Epon. Ul-
trathin sectioning was performed using a PowerTome X Ultramicrotome (RMC
products by Boeckeler, Tucson, AZ). The ultrathin sections were collected on
formvar-coated copper one-hole grids and contrasted with lead citrate and
uranyl acetate, then examined in a JEOL 100CX transmission electron micro-
scope.
Seizure Counts
Mice were placed in a sterilized Plexiglas cage with a camera embedded in the
ceiling (PhenoTyper, Noldus, Wageningen, The Netherlands) and left undis-
turbed overnight while their movements were recorded by infrared light. Six
nonoverlapping half-hour video segments were randomly selected from
each 6 hr videotape, excluding the first 3 hr segment so as to diminish any ef-
fects of the novel environment. Two segments for eachmouse scoredwere as-
signed to each of three observers, blinded as to the mouse’s age and treat-
ment. The observers recorded and timed each mouse’s seizures, which
were defined as such when the mouse fell to its side and assumed a rigid, ste-
reotypically tonic posture, typically complicated by clonic flexion-extension of
the trunk and limbs. A seizure was timed as ending when the mouse first
moved to right itself. The number of seizures per hour, and the total ictal
time per hour, were thereby scored.
Transcallosal Transmission
Mice were anesthetized with ketamine (60 mg/kg, i.p.) and xylazine (10 mg/kg,
i.p.), intubated through a tracheotomy, and ventilated with a ventilator (SAR-
830, CWE, Inc., Ardmore, PA). A femoral artery was catheterized formonitoring
mean artery blood pressure and blood gases, and body temperature was
maintained at 37C by a warming blanket (Harvard Apparatus, Holliston,
MA). Mice were secured with a custom-made metal frame that was glued to
the skull with acrylic cement. Two burr holes, each 3 mm in diameter, were
made bilaterally, centered 1–2 mm posterior to bregma and 2–3 mm from
the midline. The dura was removed and agarose (0.75% in saline) was poured564 Cell Stem Cell 2, 553–565, June 2008 ª2008 Elsevier Inc.into the craniotomy sites, which were then closed with a 0.17 mm-thick glass
coverslip. The head frame was then attached to a second frame that was cou-
pled to the microscope stage. Glass micropipettes filled with 2MNaCl solution
were then inserted to a depth of 200 mm into the right cortex, at 1.5 mm pos-
terior to bregma and 2.5 mm from the midline, for recording the local field po-
tentials (LFPs) generated by transcallosal electric stimulation. Electrical stim-
ulation (100 ms at 10–1000 mA, via an ISO-Flex isolator controlled by
a Master-8 programmer; AMPI, Israel) was applied using a bipolar electrode
inserted at the same coordinates in the contralateral (left) hemisphere. Evoked
LFPs were recorded by a MultiClamp 700A amplifier, filtered at a cutoff fre-
quency of 1 kHz, and sampled at an interval of 200 ms by a pCLAMP 9.2 pro-
gram and DigiData 1332A interface (Axon Instruments, Inc.). The same elec-
trode was used to continuously monitor the electrocorticogram (ECoG).
ECoG was recorded continuously by a MultiClamp 700A amplifier (Axon)
with a low-frequency filter at 1 Hz and high-frequency filter at 100 Hz (51,
52), and a pCLAMP 9.2 program and DigiData 1332A interface (Axon) with
an interval of 200 ms. The amplitude of stimulus-evoked transcallosal response
was then calculated as the difference between the peak and baseline, whereby
the baseline was defined as the average potential measured during the 20 ms
before the stimulation was delivered. The velocity of transcallosal response
was calculated, together with the latency of the response and the distance
between the stimulating and recording electrodes. The response latency
was defined as the difference between the stimulus start and the peak. Two
recordings of the transcallosal responses to electric stimulation (0.10 ms,
0.01–0.10 mA) were obtained from each animal.
SUPPLEMENTAL DATA
Supplemental Data include two figures and three movies and can be found
with this article online at http://www.cellstemcell.com/cgi/content/full/2/6/
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